Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis

Oncogene

Volumn 31, Issue 22, 2012, Pages 2794-2804

  Mei, Y P ^a   Liao, J P ^a   Shen, J ^a   Yu, L ^a   Liu, B L ^b   Liu, L ^a   Li, R Y ^a   Ji, L ^c   Dorsey, S G ^d   Jiang, Z R ^a   Katz, R L ^c   Wang, J Y ^a   Jiang, F ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF NURSING   (United States)

Author keywords

Apoptosis; Biomarkers; P53; Small nucleolar RNA; Tumorigenesis

Indexed keywords

PROTEIN P53; SMALL INTERFERING RNA; SMALL NUCLEOLAR RNA; SMALL NUCLEOLAR RNA 42; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRONCHUS MUCOSA; CANCER CELL CULTURE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COLONY FORMATION; EPITHELIUM CELL; FROZEN SECTION; GAIN OF FUNCTION MUTATION; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LOSS OF FUNCTION MUTATION; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; NONHUMAN; ONCOGENE; ONCOGENE KIAA0907; ONCOGENE SNORA42; PLEIOTROPY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; BLOTTING, WESTERN; BRONCHI; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; ONCOGENES; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA, SMALL NUCLEOLAR; SURVIVAL RATE;

MUS;

EID: 84861697187     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.449     Document Type: Article

References (37)

1. Albertson DG, Ylstra B, Segraves R, Collins C, Dairkee SH, Kowbel D et al. (2000). Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 25: 144-146. (Pubitemid 30394982)
2. Baek SJ, Kim KS, Nixon JB, Wilson LC, Eling TE. (2001). Cyclooxygenase inhibitors regulate the expression of a TGF-â superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol 59: 901-908. (Pubitemid 32274020)
3. Chang LS, Lin SY, Lieu AS, Wu TL. (2002). Differential expression of human 5S snoRNA genes. Biochem Biophys Res Commun 299: 196-200.
4. Dong XY, Guo P, Boyd J, Sun X, Li Q, Zhou W et al. (2009). Implication of snoRNA U50 in human breast cancer. J Genet Genomics 8: 447-454.
5. Dong XY, Rodriguez C, Guo P, Sun X, Talbot JT, Zhou W et al. (2008). SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum Mol Genet 17: 1031-1042. (Pubitemid 351426037)
6. Donsante A, Miller DG, Li Y, Vogler C, Brunt EM, Russell D.W et al. (2007). AAV vector integration sites in mouse hepatocellular carcinoma. Science 317: 477. (Pubitemid 47196106)
7. Fan T, Li R, Todd NW, Qiu Q, Fang HB, Wang H et al. (2007). Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target. Cancer Res 67: 7901-7906. (Pubitemid 47281386)
8. Filipowicz W, Pogacić V. (2002). Biogenesis of small nucleolar ribonucleoproteins. Curr Opin Cell Biol 14: 319-327. (Pubitemid 34626970)
9. Harada T, Chelala C, Bhakta V, Chaplin T, Caulee K, Baril P et al. (2008). Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays. Oncogene 27: 1951-1960. (Pubitemid 351430826)
10. Harris SL, Levine AJ. (2005). The p53 pathway: positive and negative feedback loops. Oncogene 24: 2899-2908. (Pubitemid 40638098)
11. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S et al. (2005). A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632. (Pubitemid 41541436)
12. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al. (2005). A microRNA polycistron as a potential human oncogene. Nature 435: 828-833. (Pubitemid 40839734)
13. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al (2008). Cancer statistics, 2008. CA Cancer J Clin 58: 71-96. (Pubitemid 351521864)
14. Jiang F, Todd NW, Li R, Zhang H, Fang H, Stass SA. (2010). A panel of sputum-based genomic marker for early detection of lung cancer. Cancer Prev Res (Phila) 12: 1571-1578.
15. Jiang F, Yin Z, Caraway NP, Li R, Katz RL. (2004). Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays. Neoplasia 6: 623-635. (Pubitemid 39419501)
16. Kishore S, Stamm S. (2006). The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science 311: 230-232. (Pubitemid 43108188)
17. Kiss T. (2002). Small nucleolar RNAs: an abundant group of noncoding RNAs with diverse cellular functions. Cell 109: 145-148. (Pubitemid 34518252)
18. Li R, Liu Z, Fan T, Jiang F. (2006a). A novel multiple FISH array for the detection of genetic aberrations in cancer. Lab Invest 86: 619-627. (Pubitemid 43780443)
19. Li R, Wang H, Bekele BN, Yin Z, Caraway NP, Katz RL et al. (2006b). Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach. Oncogene 25: 2628-2635.
20. Liao J, Yu L, Mei Y, GuarneraM, Shen J et al. (2010). Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer. Mol Cancer 9: 198-222.
21. Malstrom SE, Jekic-McMullen D, Sambucetti L, Ang A, Reeves R, Purchio AF et al. (2004). In vivo bioluminescent monitoring of chemical toxicity using heme oxygenase-luciferase transgenic mice. Toxicol Appl Pharmacol 200: 219-228. (Pubitemid 39422421)
22. Minna JD, Roth JA., Gazdar AF. (2002). Focus on lung cancer. Cancer Cell 1: 49-52. (Pubitemid 41039175)
23. Moasser MM. (2007). The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis. Oncogene 26: 6469-6487. (Pubitemid 47530601)
24. Mourtada-Maarabouni M, Pickard MR, Hedge VL, Farzaneh F, Williams GT. (2009). GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 28: 195-208.
25. Mu P, Han YC, Betel D, Yao E, Squatrito M, Ogrodowski P et al. (2009). Genetic dissection of the miR-17B92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev 23: 2806-2811.
26. O'Reilly MS, Pirie-Shepherd S, Lane WS, Folkman J. (1999). Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science 17: 1926-1928.
27. Pena JT, Sohn-Lee C, Rouhanifard SH, Ludwig J, Hafner M, Mihailovic A et al. (2009). miRNA in situ hybridization in formaldehyde and EDC-fixed tissues. Nat Methods 6: 139-141.
28. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I et al. (2008). E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13: 272-286. (Pubitemid 351318375)
29. Press MF, Jones LA, Godolphin W, Edwards CL, Slamon DJ. (1990). HER-2/neu oncogene amplification and expression in breast and ovarian cancers. Prog Clin Biol Res 354A: 209-221.
30. Testa JR, Liu Z, Feder M, Bell DW, Balsara B, Cheng JQ et al. (1997). Advances in the analysis of chromosome alterations in human lung carcinomas. Cancer Genet Cytogenet 95: 20-32. (Pubitemid 27188444)
31. Turner AM, Morris KV. (2010). Controlling transcription with noncoding RNAs in mammalian cells. Biotechniques 48: ix-xvi.
32. Vogelstein B, Lane D, Levine AJ. (2000). Surfing the p53 network. Nature 408: 307-310.
33. Vousden KH. (2002). Activation of the p53 tumor suppressor protein. Biochim Biophys Acta 1602: 47-59. (Pubitemid 34311899)
34. Wang X, Wang X, Varma RK, Beauchamp L, Magdaleno S, Sendera TJ. (2009). Selection of hyperfunctional siRNAs with improved potency and specificity. Nucleic Acids Res 22: e152.
35. Wall NR, Shi Y. (2003). Small RNA: can RNA interference be exploited for therapy? Lancet 362: 1401-1403. (Pubitemid 37338343)
36. Winnard Jr PT, Kluth JB, Raman V. (2006). Noninvasive optical tracking of red fluorescent protein-expressing cancer cells in a model of metastatic breast cancer. Neoplasia 8: 796-806. (Pubitemid 44564835)
37. Zhou Y, Zhong Y, Wang Y, Zhang X, Batista DL, Gejman R et al. (2007). Activation of p53 by MEG3 non-coding RNA. J Biol Chem 282: 24731-24742. (Pubitemid 47347547)